{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T03:04:13Z","timestamp":1763348653110,"version":"build-2065373602"},"reference-count":83,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,19]],"date-time":"2024-02-19T00:00:00Z","timestamp":1708300800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Taibah University Medical Sciences"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.jtumed.2024.02.003","type":"journal-article","created":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T07:54:43Z","timestamp":1708934083000},"page":"429-446","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Ligand based-design of potential schistosomiasis inhibitors through QSAR, homology modeling, molecular dynamics, pharmacokinetics, and DFT studies"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-9261-4641","authenticated-orcid":false,"given":"Saudatu C.","family":"Ja'afaru","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adamu","family":"Uzairu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anshuman","family":"Chandra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammed S.","family":"Sallau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George I.","family":"Ndukwe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad T.","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2390-1808","authenticated-orcid":false,"given":"Imteyaz","family":"Qamar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.jtumed.2024.02.003_bib1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006902","article-title":"Schistosomiasis is associated with incident HIV transmission and death in Zambia","volume":"12","author":"Wall","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.jtumed.2024.02.003_bib2","first-page":"45","volume":"1154","author":"LoVerde","year":"2019"},{"key":"10.1016\/j.jtumed.2024.02.003_bib3","unstructured":"Schistosomiasis [https:\/\/www.nhs.uk\/conditions\/schistosomiasis\/]."},{"key":"10.1016\/j.jtumed.2024.02.003_bib4","unstructured":"Schistosomiasis [https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/schistosomiasis]."},{"issue":"1","key":"10.1016\/j.jtumed.2024.02.003_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40249-021-00919-z","article-title":"The economic impact of schistosomiasis","volume":"10","author":"Rinaldo","year":"2021","journal-title":"Infect Dis Poverty"},{"key":"10.1016\/j.jtumed.2024.02.003_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.635869","article-title":"Schistosomiasis morbidity hotspots: roles of the human host, the parasite and their interface in the development of severe morbidity","volume":"12","author":"Mawa","year":"2021","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.jtumed.2024.02.003_bib7","article-title":"Schistosomiasis with a focus on Africa","volume":"6","author":"Aula","year":"2021","journal-title":"Trop Med Infect Dis"},{"key":"10.1016\/j.jtumed.2024.02.003_bib8","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.ijid.2020.10.088","article-title":"Association of schistosomiasis and HIV infections: a systematic review and meta-analysis","volume":"102","author":"Patel","year":"2021","journal-title":"Int J Infect Dis"},{"issue":"1","key":"10.1016\/j.jtumed.2024.02.003_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003472","article-title":"The influence of HIV and schistosomiasis on renal function: a cross-sectional study among children at a hospital in Tanzania","volume":"9","author":"Kayange","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"10.1016\/j.jtumed.2024.02.003_bib10","doi-asserted-by":"crossref","DOI":"10.1111\/and.13165","article-title":"Schistosomiasis (bilharziasis) and male infertility","volume":"51","author":"Abdel-Naser","year":"2019","journal-title":"Andrologia"},{"issue":"5","key":"10.1016\/j.jtumed.2024.02.003_bib11","doi-asserted-by":"crossref","first-page":"421","DOI":"10.15406\/mojph.2017.06.00186","article-title":"Menace of schistosomiasis: its true neglected nature in Nigeria","volume":"6","author":"Bishop","year":"2017","journal-title":"MOJ Public Health"},{"issue":"4","key":"10.1016\/j.jtumed.2024.02.003_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23042255","article-title":"Vaccines for human schistosomiasis: recent progress, new developments and future prospects","volume":"23","author":"Molehin","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"12","key":"10.1016\/j.jtumed.2024.02.003_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0011008","article-title":"Limited efficacy of repeated praziquantel treatment in Schistosoma mansoni infections as revealed by highly accurate diagnostics, PCR and UCP-LF CAA (RePST trial)","volume":"16","author":"Hoekstra","year":"2022","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"10.1016\/j.jtumed.2024.02.003_bib14","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.molbiopara.2014.06.002","article-title":"Schistosomiasis control: praziquantel forever?","volume":"195","author":"Cioli","year":"2014","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.jtumed.2024.02.003_bib15","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/5049532","article-title":"Omega class glutathione S-transferase: antioxidant enzyme in pathogenesis of neurodegenerative diseases","volume":"2017","author":"Kim","year":"2017","journal-title":"Oxid Med Cell Longev"},{"issue":"12","key":"10.1016\/j.jtumed.2024.02.003_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/biom11121844","article-title":"Engineering a pseudo-26-kDa schistosoma glutathione transferase from bovis\/haematobium for structure, kinetics, and ligandin studies","volume":"11","author":"Padi","year":"2021","journal-title":"Biomolecules"},{"issue":"16","key":"10.1016\/j.jtumed.2024.02.003_bib17","doi-asserted-by":"crossref","first-page":"5654","DOI":"10.1016\/S0021-9258(17)30317-4","article-title":"Glutathione transferases. Catalysis of nucleophilic reactions of glutathione","volume":"253","author":"Keen","year":"1978","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jtumed.2024.02.003_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.molbiopara.2020.111319","article-title":"Molecular basis of inhibition of Schistosoma japonicum glutathione transferase by ellagic acid: insights into biophysical and structural studies","volume":"240","author":"Akumadu","year":"2020","journal-title":"Mol Biochem Parasitol"},{"issue":"6109","key":"10.1016\/j.jtumed.2024.02.003_bib19","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/326149a0","article-title":"Molecular cloning of a protective antigen of schistosomes","volume":"326","author":"Balloul","year":"1987","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.jtumed.2024.02.003_bib20","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1006\/jmbi.1994.0061","article-title":"Crystal structures of a schistosomal drug and vaccine target: glutathione S-transferase from Schistosoma japonica and its complex with the leading antischistosomal drug praziquantel","volume":"246","author":"McTigue","year":"1995","journal-title":"J\u00a0Mol Biol"},{"issue":"625","key":"10.1016\/j.jtumed.2024.02.003_bib21","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abj5832","article-title":"Mechanism of praziquantel action at a parasitic flatworm ion channel","volume":"13","author":"Park","year":"2021","journal-title":"Sci Transl Med"},{"issue":"1","key":"10.1016\/j.jtumed.2024.02.003_bib22","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s43046-023-00182-3","article-title":"Ligand-based drug design of quinazolin-4(3H)-ones as breast cancer inhibitors using QSAR modeling, molecular docking, and pharmacological profiling","volume":"35","author":"Abdullahi","year":"2023","journal-title":"J\u00a0Egypt Natl Cancer Inst"},{"issue":"5","key":"10.1016\/j.jtumed.2024.02.003_bib23","doi-asserted-by":"crossref","first-page":"572","DOI":"10.2174\/1381612822666151125000550","article-title":"Computer aided drug design: success and limitations","volume":"22","author":"Hassan Baig","year":"2016","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.jtumed.2024.02.003_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcab.2023.102787","article-title":"Computational design of quinoxaline molecules as VEGFR-2 inhibitors: QSAR modelling, pharmacokinetics, molecular docking, and dynamics simulation studies","volume":"51","author":"Abdullahi","year":"2023","journal-title":"Biocatal Agric Biotechnol"},{"key":"10.1016\/j.jtumed.2024.02.003_bib25","article-title":"Molecular docking studies of some benzoxazole and benzothiazole derivatives as VEGFR-2 target inhibitors: in silico design, MD simulation, pharmacokinetics and DFT studies","author":"Abdullahi","year":"2023","journal-title":"Intell Pharm"},{"issue":"9","key":"10.1016\/j.jtumed.2024.02.003_bib26","doi-asserted-by":"crossref","first-page":"3906","DOI":"10.3390\/molecules28093906","article-title":"Past, present, and future perspectives on computer-aided drug design methodologies","volume":"28","author":"Bassani","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.jtumed.2024.02.003_bib27","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/978-1-0716-0607-0_6","article-title":"Computational approaches in drug designing and their applications","author":"Singh","year":"2020","journal-title":"Exp Protoc Biotechnol"},{"issue":"7","key":"10.1016\/j.jtumed.2024.02.003_bib28","article-title":"Unsymmetrical aromatic disulfides as SARS-CoV-2 Mpro inhibitors: molecular docking, molecular dynamics, and ADME scoring investigations","volume":"34","author":"Chtita","year":"2022","journal-title":"J\u00a0King Saud Univ Sci"},{"issue":"12","key":"10.1016\/j.jtumed.2024.02.003_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e11991","article-title":"Combined computational approaches for developing new anti-Alzheimer drug candidates: 3D-QSAR, molecular docking and molecular dynamics studies of liquiritigenin derivatives","volume":"8","author":"Nour","year":"2022","journal-title":"Heliyon"},{"issue":"5","key":"10.1016\/j.jtumed.2024.02.003_bib30","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1007\/s11224-022-01939-7","article-title":"In silico investigation of phytoconstituents from Cameroonian medicinal plants towards COVID-19 treatment","volume":"33","author":"Chtita","year":"2022","journal-title":"Struct Chem"},{"issue":"1","key":"10.1016\/j.jtumed.2024.02.003_bib31","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1186\/s12859-019-3135-4","article-title":"Comprehensive ensemble in QSAR prediction for drug discovery","volume":"20","author":"Kwon","year":"2019","journal-title":"BMC Bioinform"},{"issue":"2","key":"10.1016\/j.jtumed.2024.02.003_bib32","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/bkcs.12449","article-title":"2D-QSAR and molecular docking studies of carbamate derivatives to discover novel potent anti-butyrylcholinesterase agents for Alzheimer's disease treatment","volume":"43","author":"Nour","year":"2022","journal-title":"Bull Kor Chem Soc"},{"issue":"1","key":"10.1016\/j.jtumed.2024.02.003_bib33","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/s42269-022-00869-y","article-title":"Computational modeling, ligand-based drug design, drug-likeness and ADMET properties studies of series of chromen-2-ones analogues as anti-cancer agents","volume":"46","author":"Abdullahi","year":"2022","journal-title":"Bull Natl Res Cent"},{"issue":"1","key":"10.1016\/j.jtumed.2024.02.003_bib34","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s42269-022-00853-6","article-title":"Salicylic acid derivatives as potential \u03b1-glucosidase inhibitors: drug design, molecular docking and pharmacokinetic studies","volume":"46","author":"Aminu","year":"2022","journal-title":"Bull Natl Res Cent"},{"issue":"21","key":"10.1016\/j.jtumed.2024.02.003_bib35","doi-asserted-by":"crossref","DOI":"10.1021\/ja204075s","article-title":"Computer review of ChemDraw ultra 12.0","volume":"133","author":"Cousins","year":"2011","journal-title":"J\u00a0Am Chem Soc"},{"issue":"5","key":"10.1016\/j.jtumed.2024.02.003_bib36","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1021\/ci049794h","article-title":"Personal experience with four kinds of chemical structure drawing software: review on ChemDraw, ChemWindow, ISIS\/draw, and ChemSketch","volume":"44","author":"Li","year":"2004","journal-title":"J\u00a0Chem Inf Comput Sci"},{"issue":"1","key":"10.1016\/j.jtumed.2024.02.003_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2020.e03158","article-title":"In-silico activity prediction and docking studies of some 2, 9-disubstituted 8-phenylthio\/phenylsulfinyl-9h-purine derivatives as Anti-proliferative agents","volume":"6","author":"Ibrahim","year":"2020","journal-title":"Heliyon"},{"issue":"1","key":"10.1016\/j.jtumed.2024.02.003_bib38","first-page":"180","article-title":"Molecular docking, ADMET and pharmacokinetic properties predictions of some di-aryl pyridinamine derivatives as estrogen receptor (Er+) kinase inhibitors","volume":"9","author":"Abdullahi","year":"2022","journal-title":"Egypt J Basic Appl Sci"},{"issue":"7","key":"10.1016\/j.jtumed.2024.02.003_bib39","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1002\/jcc.21707","article-title":"PaDEL-descriptor: an open source software to calculate molecular descriptors and fingerprints","volume":"32","author":"Yap","year":"2011","journal-title":"J\u00a0Comput Chem"},{"key":"10.1016\/j.jtumed.2024.02.003_bib40","article-title":"The anti-SARS-CoV-2 activity of novel 9, 10-dihydrophenanthrene derivatives: an insight into molecular docking, ADMET analysis, and molecular dynamics simulation","volume":"21","author":"Yamari","year":"2023","journal-title":"Sci Afr"},{"issue":"5","key":"10.1016\/j.jtumed.2024.02.003_bib41","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s42452-020-2620-8","article-title":"Design of potential anti-melanoma agents against SK-MEL-5 cell line using QSAR modeling and molecular docking methods","volume":"2","author":"Umar","year":"2020","journal-title":"SN Appl Sci"},{"key":"10.1016\/j.jtumed.2024.02.003_bib42","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0169-7439(02)00110-7","article-title":"Separation of data on the training and test set for modelling: a case study for modelling of five colour properties of a white pigment","volume":"65","author":"Rajer-Kandu\u010d","year":"2003","journal-title":"Chemometr Intell Lab Syst"},{"issue":"1","key":"10.1016\/j.jtumed.2024.02.003_bib43","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1080\/00401706.1969.10490666","article-title":"Computer aided design of experiments","volume":"11","author":"Kennard","year":"1969","journal-title":"Technometrics"},{"issue":"4","key":"10.1016\/j.jtumed.2024.02.003_bib44","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1007\/s42250-020-00191-y","article-title":"Lead identification of some anti-cancer agents with prominent activity against non-small cell lung cancer (NSCLC) and structure-based design","volume":"3","author":"Ibrahim","year":"2020","journal-title":"Chem Afr"},{"issue":"1","key":"10.1016\/j.jtumed.2024.02.003_bib45","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s42269-020-00389-7","article-title":"Quantitative structure-activity relationship (QSAR) modelling study of some novel carboxamide series as new anti-tubercular agents","volume":"44","author":"Abdullahi","year":"2020","journal-title":"Bull Natl Res Cent"},{"issue":"1","key":"10.1016\/j.jtumed.2024.02.003_bib46","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s43094-021-00279-3","article-title":"Design of more potent quinazoline derivatives as EGFRWT inhibitors for the treatment of NSCLC: a computational approach","volume":"7","author":"Ibrahim","year":"2021","journal-title":"Fut J Pharm Sci"},{"issue":"1","key":"10.1016\/j.jtumed.2024.02.003_bib47","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s43042-021-00181-w","article-title":"Computer-aided design of some quinazoline analogues as epidermal growth factor receptor inhibitors","volume":"22","author":"Ibrahim","year":"2021","journal-title":"Egypt J Med Hum Genet"},{"issue":"1","key":"10.1016\/j.jtumed.2024.02.003_bib48","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s43094-020-00084-4","article-title":"In silico evaluation of some 4-(quinolin-2-yl)pyrimidin-2-amine derivatives as potent V600E-BRAF inhibitors with pharmacokinetics ADMET and drug-likeness predictions","volume":"6","author":"Umar","year":"2020","journal-title":"Fut J Pharm Sci"},{"key":"10.1016\/j.jtumed.2024.02.003_bib49","first-page":"511","article-title":"Validation of QSAR models \u2013 strategies and importance","volume":"2","author":"Veerasamy","year":"2011","journal-title":"Int J Drug Des Discov"},{"key":"10.1016\/j.jtumed.2024.02.003_bib50","article-title":"On the use of r and r squared in correlation and regression","volume":"34","author":"Kasuya","year":"2018","journal-title":"Ecol Res"},{"issue":"5","key":"10.1016\/j.jtumed.2024.02.003_bib51","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.3390\/molecules14051660","article-title":"On two novel parameters for validation of predictive QSAR models","volume":"14","author":"Pratim Roy","year":"2009","journal-title":"Molecules"},{"key":"10.1016\/j.jtumed.2024.02.003_bib52","article-title":"Structure-based design and activity modeling of novel epidermal growth factor receptor kinase inhibitors; an in silico approach","volume":"9","author":"Ibrahim","year":"2020","journal-title":"Sci Afr"},{"issue":"3","key":"10.1016\/j.jtumed.2024.02.003_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2020.e03449","article-title":"QSAR and molecular docking studies of 1,3-dioxoisoindoline-4-aminoquinolines as potent antiplasmodium hybrid compounds","volume":"6","author":"Mahmud","year":"2020","journal-title":"Heliyon"},{"issue":"1","key":"10.1016\/j.jtumed.2024.02.003_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s43042-020-00126-9","article-title":"Ligand-based drug design and molecular docking simulation studies of some novel anticancer compounds on MALME-3M melanoma cell line","volume":"22","author":"Umar","year":"2021","journal-title":"Egypt J Med Hum Genet"},{"issue":"4","key":"10.1016\/j.jtumed.2024.02.003_bib55","first-page":"269","article-title":"Homology modelling of the dihydrofolate reductase-thymidylate synthase bifunctional enzyme of Leishmania major, a potential target for rational drug design in leishmaniasis","volume":"11","author":"McKie","year":"1994","journal-title":"Drug Des Discov"},{"issue":"1","key":"10.1016\/j.jtumed.2024.02.003_bib56","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1186\/1471-2105-10-421","article-title":"BLAST+: architecture and applications","volume":"10","author":"Camacho","year":"2009","journal-title":"BMC Bioinform"},{"issue":"2","key":"10.1016\/j.jtumed.2024.02.003_bib57","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/nmeth.1818","article-title":"HHblits: lightning-fast iterative protein sequence searching by HMM-HMM alignment","volume":"9","author":"Remmert","year":"2012","journal-title":"Nat Methods"},{"issue":"W1","key":"10.1016\/j.jtumed.2024.02.003_bib58","doi-asserted-by":"crossref","first-page":"W296","DOI":"10.1093\/nar\/gky427","article-title":"SWISS-MODEL: homology modelling of protein structures and complexes","volume":"46","author":"Waterhouse","year":"2018","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"10.1016\/j.jtumed.2024.02.003_bib59","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1093\/bioinformatics\/btq662","article-title":"Toward the estimation of the absolute quality of individual protein structure models","volume":"27","author":"Benkert","year":"2010","journal-title":"Bioinformatics"},{"issue":"1","key":"10.1016\/j.jtumed.2024.02.003_bib60","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s42269-021-00631-w","article-title":"Chemo-informatics activity prediction, ligand based drug design, molecular docking and pharmacokinetics studies of some series of 4, 6-diaryl-2-pyrimidinamine derivatives as anti-cancer agents","volume":"45","author":"Abdullahi","year":"2021","journal-title":"Bull Natl Res Cent"},{"issue":"18","key":"10.1016\/j.jtumed.2024.02.003_bib61","doi-asserted-by":"crossref","first-page":"5343","DOI":"10.1016\/j.bmc.2011.11.064","article-title":"Softening the rule of five \u2013 where to draw the line?","volume":"20","author":"Petit","year":"2012","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.jtumed.2024.02.003_bib62","first-page":"46","article-title":"A\u00a0brief review on importance of DFT in drug design","volume":"39","author":"Tandon","year":"2019","journal-title":"Res Med Eng Stud"},{"issue":"5","key":"10.1016\/j.jtumed.2024.02.003_bib63","first-page":"933","article-title":"Virtual screening, pharmacokinetic, and DFT studies of anticancer compounds as potential V600E-BRAF kinase inhibitors","volume":"18","author":"Umar","year":"2023","journal-title":"J\u00a0Taibah Univ Med Sci"},{"issue":"1","key":"10.1016\/j.jtumed.2024.02.003_bib64","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s42269-021-00690-z","article-title":"In-silico activity prediction, structure-based drug design, molecular docking and pharmacokinetic studies of selected quinazoline derivatives for their antiproliferative activity against triple negative breast cancer (MDA-MB231) cell line","volume":"46","author":"Abdullahi","year":"2022","journal-title":"Bull Natl Res Cent"},{"key":"10.1016\/j.jtumed.2024.02.003_bib65","first-page":"37","article-title":"Molecular dynamics simulations: advances and applications","volume":"8","author":"Hospital","year":"2015","journal-title":"Comput Biol Chem Adv Appl"},{"issue":"1","key":"10.1016\/j.jtumed.2024.02.003_bib66","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s43088-019-0023-y","article-title":"In silico QSAR and molecular docking simulation of some novel aryl sulfonamide derivatives as inhibitors of H5N1 influenza A virus subtype","volume":"9","author":"Abdullahi","year":"2020","journal-title":"Beni-Suef Univ J Basic Appl Sci"},{"issue":"6\u20137","key":"10.1016\/j.jtumed.2024.02.003_bib67","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/minf.201000061","article-title":"Best practices for QSAR model development, validation, and exploitation","volume":"29","author":"Tropsha","year":"2010","journal-title":"Mol inf"},{"issue":"1","key":"10.1016\/j.jtumed.2024.02.003_bib68","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s43088-020-00077-5","article-title":"Quantitative structure-activity relationship, molecular docking, drug-likeness, and pharmacokinetic studies of some non-small cell lung cancer therapeutic agents","volume":"9","author":"Ibrahim","year":"2020","journal-title":"Beni-Suef Univ J Basic Appl Sci"},{"issue":"3","key":"10.1016\/j.jtumed.2024.02.003_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2020.e03640","article-title":"QSAR modelling and molecular docking studies for anti-cancer compounds against melanoma cell line SK-MEL-2","volume":"6","author":"Umar","year":"2020","journal-title":"Heliyon"},{"key":"10.1016\/j.jtumed.2024.02.003_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.cdc.2022.100911","article-title":"Ligand-based drug design, molecular docking and pharmacokinetic studies of some series of 1,4 \u2013 dihydropyridines derivatives as human intestinal maltase-glucoamylase inhibitor","volume":"41","author":"Aminu","year":"2022","journal-title":"Chem Data Collect"},{"key":"10.1016\/j.jtumed.2024.02.003_bib71","article-title":"QSAR modeling and molecular docking analysis of some active compounds against Mycobacterium tuberculosis receptor (Mtb CYP121)","volume":"2018","author":"Adeniji","year":"2018","journal-title":"J\u00a0Pathog"},{"issue":"8\u20139","key":"10.1016\/j.jtumed.2024.02.003_bib72","article-title":"Value of p-Value","volume":"38","author":"Golbraikh","year":"2019","journal-title":"Mol Inf"},{"key":"10.1016\/j.jtumed.2024.02.003_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.chemosphere.2020.127217","article-title":"QSAR modeling the toxicity of pesticides against Americamysis bahia","volume":"258","author":"Yang","year":"2020","journal-title":"Chemosphere"},{"issue":"2","key":"10.1016\/j.jtumed.2024.02.003_bib74","first-page":"295","article-title":"2D-QSAR, molecular docking, drug-likeness, and ADMET\/pharmacokinetic predictions of some non-small cell lung cancer therapeutic agents","volume":"18","author":"Ibrahim","year":"2023","journal-title":"J\u00a0Taibah Univ Med Sci"},{"issue":"7","key":"10.1016\/j.jtumed.2024.02.003_bib75","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1517\/17460441.2010.492827","article-title":"Advances in computational methods to predict the biological activity of compounds","volume":"5","author":"Nantasenamat","year":"2010","journal-title":"Expet Opin Drug Discov"},{"key":"10.1016\/j.jtumed.2024.02.003_bib76","series-title":"Computational chemogenomics","first-page":"171","article-title":"Impact of molecular descriptors on computational models","author":"Grisoni","year":"2018"},{"key":"10.1016\/j.jtumed.2024.02.003_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2014.03.035","article-title":"Predicting the bioconcentration factor of highly hydrophobic organic chemicals","volume":"69","author":"Garg","year":"2014","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.jtumed.2024.02.003_bib78","series-title":"Symmetry (group theory) and Mathematical treatment in chemistry","article-title":"Molecular descriptors and properties of organic molecules","author":"Amalia","year":"2018"},{"key":"10.1016\/j.jtumed.2024.02.003_bib79","article-title":"Exploration of Cannabis constituents as potential candidates against diabetes mellitus disease using molecular docking, dynamics simulations and ADMET investigations","volume":"21","author":"Abchir","year":"2023","journal-title":"Sci Afr"},{"issue":"26","key":"10.1016\/j.jtumed.2024.02.003_bib80","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202301092","article-title":"Structure-based virtual screening, ADMET analysis, and molecular dynamics simulation of Moroccan natural compounds as candidates \u03b1-amylase inhibitors","volume":"8","author":"Abchir","year":"2023","journal-title":"ChemistrySelect"},{"issue":"9","key":"10.1016\/j.jtumed.2024.02.003_bib81","doi-asserted-by":"crossref","first-page":"4035","DOI":"10.1021\/acs.jmedchem.5b01684","article-title":"Role of molecular dynamics and related methods in drug discovery","volume":"59","author":"De Vivo","year":"2016","journal-title":"J\u00a0Med Chem"},{"issue":"5","key":"10.1016\/j.jtumed.2024.02.003_bib82","first-page":"1018","article-title":"Pharmacokinetic profiling of quinazoline-4(3H)-one analogs as EGFR inhibitors: 3D-QSAR modeling, molecular docking studies and the design of therapeutic agents","volume":"18","author":"Abdullahi","year":"2023","journal-title":"J\u00a0Taibah Univ Med Sci"},{"key":"10.1016\/j.jtumed.2024.02.003_bib83","doi-asserted-by":"crossref","DOI":"10.1007\/s42250-023-00592-9","article-title":"2D and 3D-QSAR modeling of 1H-pyrazole derivatives as EGFR inhibitors: molecular docking, and pharmacokinetic profiling","author":"Abdullahi","year":"2023","journal-title":"Chem Afr"}],"container-title":["Journal of Taibah University Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S165836122400009X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S165836122400009X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T10:33:46Z","timestamp":1761647626000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S165836122400009X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":83,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S165836122400009X"],"URL":"https:\/\/doi.org\/10.1016\/j.jtumed.2024.02.003","relation":{},"ISSN":["1658-3612"],"issn-type":[{"type":"print","value":"1658-3612"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ligand based-design of potential schistosomiasis inhibitors through QSAR, homology modeling, molecular dynamics, pharmacokinetics, and DFT studies","name":"articletitle","label":"Article Title"},{"value":"Journal of Taibah University Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtumed.2024.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}